Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry

Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry

Background: The tumor suppressor in lung cancer-1 (TSLC1) is a tumor-suppressor gene. We evaluated the correlation between TSLC1 expression and clinicopathological characteristics of colorectal cancer patients by comparing primary colorectal cancer and adjacent normal colorectal tissues. Methods:...

Full description

Bibliographic Details
Main Author:	Mehdi Nikbakht Dastjerdi
Format:	Article
Language:	fas
Published:	Vesnu Publications 2012-05-01
Series:	مجله دانشکده پزشکی اصفهان
Online Access:	http://jims.mui.ac.ir/index.php/jims/article/view/1519

Similar Items

Comparative Investigation of TSLC1 Tumor Suppressor Protein Expression in Cancerous and Normal Ovarian Specimens
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2013-09-01)

Comparative Analysis of APC Tumor Suppressor Protein Expression in Cancerous and Normal Colorectal Specimens by Immunohistochemistry
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2011-12-01)

Comparative Expression of Breast Cancer 1 Tumor Suppressor Protein in Cancerous and Healthy Colorectal Specimens
by: Mehdi Nikbakht-Dastjerdi, et al.
Published: (2016-03-01)

A Comparative Survey on the Expression of Retinoblastoma Protein as A Tumor Suppressor Protein in Cancerous and Non-Cancerous Colorectal Tissue Samples Using Immunohistochemistry Method
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2012-08-01)

A Comparative Survey on the Expression of P16 as a Tumor Suppressor Protein in Cancerous and Non-Cancerous Colorectal Tissue Samples Using Immunohistochemistry Method
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2012-08-01)

Comparative Investigation of DAL-1 Tumor Suppressor Protein Expression in Cancerous and Normal Ovarian Specimens
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2013-10-01)

TP53 Codon 72 Polymorphism and P53 Protein Expression in Colorectal Cancer Specimens in Isfahan
by: Mehdi Nikbahkt Dastjerdi
Published: (2011-02-01)

TP53 codon 72 Polymorphism and P53 Protein Expression in Colorectal Cancer Specimens in Isfahan
by: Mehdi Nikbahkt Dastjerdi
Published: (2011-02-01)

<it>Tumor suppressor in lung cancer 1 (TSLC1) </it>alters tumorigenic growth properties and gene expression
by: Murakami Yoshinori, et al.
Published: (2005-08-01)

Expressions and Clinical Significances of TSLC1 and 4.1B in Non-small Cell Lung Cancer
by: Zhenhua WANG, et al.
Published: (2010-11-01)

Involvement of TSLC1 in progression of esophageal squamous cell carcinoma
by: Ito, Tetsuo
Published: (2011)

The Frequency of Exon 2 Mutations of KLF6 Tumor Suppressor Gene in Prostate Cancer Specimens
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2012-02-01)

The Relationship between the TSLC1 Silencing and DNA Methylation in Human Lung Cancer Cells
by: Tieying SUN, et al.
Published: (2010-05-01)

Effects of TSLC1 overexpression by adenovirus on proliferation, invasion and angiogenesis of cervical cancer cells
by: Fan-Ling Cheng1, et al.
Published: (2017-05-01)

Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
by: De Zeng, et al.
Published: (2016-01-01)

Immunohistochemistry for myc predicts survival in colorectal cancer.
by: Christopher W Toon, et al.
Published: (2014-01-01)

CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.
by: Kiruthika Manivannan, et al.
Published: (2016-04-01)

RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
by: Maxim Sorokin, et al.
Published: (2020-05-01)

MicroRNA-873 Promotes Cell Proliferation, Migration, and Invasion by Directly Targeting TSLC1 in Hepatocellular Carcinoma
by: Guoyong Han, et al.
Published: (2018-05-01)

Immunohistochemistry of Programmed Cell Death in Archival Human Pathology Specimens
by: Takami Matsuyama, et al.
Published: (2012-05-01)

Clinical significance of CADM1/TSLC1/IgSF4 expression in Adult-T cell leukemia/lymphoma (ATLL): identification of various types of ATLL cells
by: Ukai Yoshinori, et al.
Published: (2011-06-01)

The Prognostic Role of STEAP1 Expression Determined via Immunohistochemistry Staining in Predicting Prognosis of Primary Colorectal Cancer: A Survival Analysis
by: Ching-Hsiao Lee, et al.
Published: (2016-04-01)

A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer
by: Philip W. Voorneveld, MD, et al.
Published: (2015-02-01)

Immunohistochemistry of colorectal cancer biomarker phosphorylation requires controlled tissue fixation.
by: Abbey P Theiss, et al.
Published: (2014-01-01)

Supporting instructors to promote at-promise students’ success: How faculty coordinators facilitate TSLC’s ecological validation
by: Toccoli, Jonathan
Published: (2021)

The role of immunohistochemistry in the detection of vascular invasion in specimens of endoscopic submucosal dissection
by: Nayze Lucena Sangreman Aldeman, et al.
Published: (2013-08-01)

Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer
by: Franceska Dedeurwaerdere, et al.
Published: (2021-06-01)

SLCO1B3 screening in colorectal cancer patients using High-Resolution Melting Analysis method and immunohistochemistry
by: Lampri Evangeli, et al.
Published: (2017-03-01)

Immunohistochemistry expression of TCF4 protein on carcinoma, adenoma and non neoplastic colorectal mucosa
by: Leonardo Huber Tauil, et al.
Published: (2014-01-01)

Immunohistochemistry - Microarray Analysis of Patients with Peritoneal Metastases of Appendiceal or Colorectal Origin
by: Danielle E Green, et al.
Published: (2015-01-01)

Study of P33 Tumor Suppressor Protein Expression in Normal and Cancerous Colorectal Tissues
by: Mehdi Nikbakht, et al.
Published: (2010-11-01)

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
by: Chen Xu, et al.
Published: (2017-05-01)

Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
by: Jiyoon Jung, et al.
Published: (2017-03-01)

MLH1 and MSH2 mismatch repair protein profile using immunohistochemistry in Nepalese colorectal cancer patients
by: Matrika Bhattarai, et al.
Published: (2020-07-01)

Frequent Hypermethylation of RASSF1A, TSLC1, High Viral Load of Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma, Matched Tumor-Adjacent Tissues
by: Liang Zhou, et al.
Published: (2005-09-01)

Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
by: Asmaa Gaber Abdou, et al.
Published: (2018-11-01)

The THE FREQUENCY OF MISMATCH REPAIR DEFICIENCY IN COLORECTAL CARCINOMA DETERMINED BY IMMUNOHISTOCHEMISTRY
by: Maria Naseem, et al.
Published: (2021-08-01)

KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?
by: Nicolas Piton, et al.
Published: (2015-01-01)

Histopathological spectrum of 364 prostatic specimens including immunohistochemistry with special reference to grey zone lesions
by: Monika Garg, et al.
Published: (2013-12-01)

Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring V600E Mutation
by: Jeong-Hwa Kwon, et al.
Published: (2018-05-01)

Cannot write session to /tmp/vufind_sessions/sess_o75cefcahjbm47sja81gpe9htv